Scientific and research activity

1
Professional
collaboration

Preclinical drug testing and development projects of the company are carried out at globally recognized research institutions based in Russia and abroad

Geography of
collaboration

The locations cover a total of 18 countries, including major EU, US and Asian Universities, Institutes and CROs

Strong research
activity

Over three years, 86 studies have been conducted

abroad: 45
in Russia: 36
2
Modern
research methods

Using most recent pharmacology techniques which meet the national and global standards is ensured by collaboration with accredited pre-clinical research centers located in Russia and worldwide

3
Discovering
and Research

Our R&D activity includes in-depth mechanism of action studies on the company’s products, as well as drug discovery and target identification projects

4
Modern
laboratory facilities

Our R&D laboratory is working to design novel QC systems and performs innovative basic research into drug development with the use of certified equipment and advanced methods, such as spectral assays, cellular techniques and immunosensors.

5
Drug’s quality
control

The R&D biotechnology projects we carry out in collaboration with Russian and foreign experts consistently contribute to the improvement of existing methods and development of new experimental techniques for use in research, production and quality control of the company’s products

10
Geography of
collaboration

Our biotechnology work involves institutions in 10 countries, including largest EU and Asian Institutes and CROs

Strong research
activity

Over 3 years, 35 studies have been conducted:
in Russia: 26 and abroad: 9

6
Peer-reviewed
journals

The results of our research projects are available as monographs and articles in Russian and foreign scientific publications, and are regularly announced at international congresses and conferences held throughout Russia and abroad.

Продакт-менеджер (ОТС)
Scientific research
  1. Don E., Farafonova O., Pokhil S., Barykina D., Nikiforova M., Shulga D., Borshcheva A., Tarasov S., Ermolaeva T., Epstein O. (2016). Use of Piezoelectric Immunosensors for Detection of Interferon-Gamma Interaction with Specific Antibodies in the Presence of Released-Active Forms of Antibodies to Interferon-Gamma. Sensors, 16(1), 96. doi: 10.3390/s16010096.
    https://www.ncbi.nlm.nih.gov/pubmed/26791304
    http://www.mdpi.com/1424-8220/16/1/96
  2. Gavrilova E.S., Bobrovnik S.A., Sherriff G., Myslivets A.A., Tarasov S.A., Epstein O.I. (2014). Novel approach to activity evaluation for release-active forms of anti-interferon-gamma antibodies based on enzyme-linked immunoassay. PloS one, 9(5), e97017. doi: 10.1371/journal.pone.0097017.
    https://www.ncbi.nlm.nih.gov/pubmed/24816648
    http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0097017
  3. Pschenitza M., Gavrilova Е.S., Tarasov S.А., Knopp D., Niessner R., Epstein О.I. (2014). Application of a heterogeneous immunoassay for the quality control testing of release-active forms of diclofenac. International immunopharmacology, 21(1), 225-230.
    https://www.ncbi.nlm.nih.gov/pubmed/24836753
  4. Sakat S.S., Mani K., Demidchenko Y.O., Gorbunov E.A., Tarasov S.A., Mathur A., Epstein, O.I. (2014). Release-active dilutions of diclofenac enhance anti-inflammatory effect of diclofenac in carrageenan-induced rat paw edema model. Inflammation, 37(1), 1-9.
    https://www.ncbi.nlm.nih.gov/pubmed/24005897
    http://link.springer.com/article/10.1007%2Fs10753-013-9705-0